Report Detail
Global Novel Vaccine Delivery Systems Market Growth (Status and Outlook) 2022-2028
- RnM4389613 |
- 02 March, 2022 |
- Global |
- 104 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
As the global economy mends, the 2021 growth of Novel Vaccine Delivery Systems will have significant change from previous year. According to our (LP Information) latest study, the global Novel Vaccine Delivery Systems market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global Novel Vaccine Delivery Systems market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.
The United States Novel Vaccine Delivery Systems market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Novel Vaccine Delivery Systems market, reaching US$ million by the year 2028. As for the Europe Novel Vaccine Delivery Systems landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Novel Vaccine Delivery Systems players cover Altaris Capital Partners, Kindeva Drug Delivery, Becton, and Dickinson,, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Novel Vaccine Delivery Systems market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Intramuscular Delivery
Intramuscular Delivery
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospitals & Clinics
Research Institutes
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Altaris Capital Partners
Kindeva Drug Delivery
Becton
Dickinson,
Carl Zeiss Foundation
Gerresheimer AG
Corium International
Inovio Pharmaceuticals
Bioject Medical Technologies
PharmaJet
Retractable Technologies
Terumo Corporation
VAXXAS
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Years Considered
- 1.3 Research Objectives
- 1.4 Market Research Methodology
- 1.5 Research Process and Data Source
- 1.6 Economic Indicators
- 1.7 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Novel Vaccine Delivery Systems Market Size 2017-2028
- 2.1.2 Novel Vaccine Delivery Systems Market Size CAGR by Region 2017 VS 2022 VS 2028
- 2.2 Novel Vaccine Delivery Systems Segment by Type
- 2.2.1 Intramuscular Delivery
- 2.2.2 Intramuscular Delivery
- 2.2.3 Others
- 2.3 Novel Vaccine Delivery Systems Market Size by Type
- 2.3.1 Novel Vaccine Delivery Systems Market Size CAGR by Type (2017 VS 2022 VS 2028)
- 2.3.2 Global Novel Vaccine Delivery Systems Market Size Market Share by Type (2017-2022)
- 2.4 Novel Vaccine Delivery Systems Segment by Application
- 2.4.1 Hospitals & Clinics
- 2.4.2 Research Institutes
- 2.4.3 Others
- 2.5 Novel Vaccine Delivery Systems Market Size by Application
- 2.5.1 Novel Vaccine Delivery Systems Market Size CAGR by Application (2017 VS 2022 VS 2028)
- 2.5.2 Global Novel Vaccine Delivery Systems Market Size Market Share by Application (2017-2022)
3 Novel Vaccine Delivery Systems Market Size by Player
- 3.1 Novel Vaccine Delivery Systems Market Size Market Share by Players
- 3.1.1 Global Novel Vaccine Delivery Systems Revenue by Players (2020-2022)
- 3.1.2 Global Novel Vaccine Delivery Systems Revenue Market Share by Players (2020-2022)
- 3.2 Global Novel Vaccine Delivery Systems Key Players Head office and Products Offered
- 3.3 Market Concentration Rate Analysis
- 3.3.1 Competition Landscape Analysis
- 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
- 3.4 New Products and Potential Entrants
- 3.5 Mergers & Acquisitions, Expansion
4 Novel Vaccine Delivery Systems by Regions
- 4.1 Novel Vaccine Delivery Systems Market Size by Regions (2017-2022)
- 4.2 Americas Novel Vaccine Delivery Systems Market Size Growth (2017-2022)
- 4.3 APAC Novel Vaccine Delivery Systems Market Size Growth (2017-2022)
- 4.4 Europe Novel Vaccine Delivery Systems Market Size Growth (2017-2022)
- 4.5 Middle East & Africa Novel Vaccine Delivery Systems Market Size Growth (2017-2022)
5 Americas
- 5.1 Americas Novel Vaccine Delivery Systems Market Size by Country (2017-2022)
- 5.2 Americas Novel Vaccine Delivery Systems Market Size by Type (2017-2022)
- 5.3 Americas Novel Vaccine Delivery Systems Market Size by Application (2017-2022)
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Brazil
6 APAC
- 6.1 APAC Novel Vaccine Delivery Systems Market Size by Region (2017-2022)
- 6.2 APAC Novel Vaccine Delivery Systems Market Size by Type (2017-2022)
- 6.3 APAC Novel Vaccine Delivery Systems Market Size by Application (2017-2022)
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
7 Europe
- 7.1 Europe Novel Vaccine Delivery Systems by Country (2017-2022)
- 7.2 Europe Novel Vaccine Delivery Systems Market Size by Type (2017-2022)
- 7.3 Europe Novel Vaccine Delivery Systems Market Size by Application (2017-2022)
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
8 Middle East & Africa
- 8.1 Middle East & Africa Novel Vaccine Delivery Systems by Region (2017-2022)
- 8.2 Middle East & Africa Novel Vaccine Delivery Systems Market Size by Type (2017-2022)
- 8.3 Middle East & Africa Novel Vaccine Delivery Systems Market Size by Application (2017-2022)
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers & Growth Opportunities
- 9.2 Market Challenges & Risks
- 9.3 Industry Trends
10 Global Novel Vaccine Delivery Systems Market Forecast
- 10.1 Global Novel Vaccine Delivery Systems Forecast by Regions (2023-2028)
- 10.1.1 Global Novel Vaccine Delivery Systems Forecast by Regions (2023-2028)
- 10.1.2 Americas Novel Vaccine Delivery Systems Forecast
- 10.1.3 APAC Novel Vaccine Delivery Systems Forecast
- 10.1.4 Europe Novel Vaccine Delivery Systems Forecast
- 10.1.5 Middle East & Africa Novel Vaccine Delivery Systems Forecast
- 10.2 Americas Novel Vaccine Delivery Systems Forecast by Country (2023-2028)
- 10.2.1 United States Novel Vaccine Delivery Systems Market Forecast
- 10.2.2 Canada Novel Vaccine Delivery Systems Market Forecast
- 10.2.3 Mexico Novel Vaccine Delivery Systems Market Forecast
- 10.2.4 Brazil Novel Vaccine Delivery Systems Market Forecast
- 10.3 APAC Novel Vaccine Delivery Systems Forecast by Region (2023-2028)
- 10.3.1 China Novel Vaccine Delivery Systems Market Forecast
- 10.3.2 Japan Novel Vaccine Delivery Systems Market Forecast
- 10.3.3 Korea Novel Vaccine Delivery Systems Market Forecast
- 10.3.4 Southeast Asia Novel Vaccine Delivery Systems Market Forecast
- 10.3.5 India Novel Vaccine Delivery Systems Market Forecast
- 10.3.6 Australia Novel Vaccine Delivery Systems Market Forecast
- 10.4 Europe Novel Vaccine Delivery Systems Forecast by Country (2023-2028)
- 10.4.1 Germany Novel Vaccine Delivery Systems Market Forecast
- 10.4.2 France Novel Vaccine Delivery Systems Market Forecast
- 10.4.3 UK Novel Vaccine Delivery Systems Market Forecast
- 10.4.4 Italy Novel Vaccine Delivery Systems Market Forecast
- 10.4.5 Russia Novel Vaccine Delivery Systems Market Forecast
- 10.5 Middle East & Africa Novel Vaccine Delivery Systems Forecast by Region (2023-2028)
- 10.5.1 Egypt Novel Vaccine Delivery Systems Market Forecast
- 10.5.2 South Africa Novel Vaccine Delivery Systems Market Forecast
- 10.5.3 Israel Novel Vaccine Delivery Systems Market Forecast
- 10.5.4 Turkey Novel Vaccine Delivery Systems Market Forecast
- 10.5.5 GCC Countries Novel Vaccine Delivery Systems Market Forecast
- 10.6 Global Novel Vaccine Delivery Systems Forecast by Type (2023-2028)
- 10.7 Global Novel Vaccine Delivery Systems Forecast by Application (2023-2028)
11 Key Players Analysis
- 11.1 Altaris Capital Partners
- 11.1.1 Altaris Capital Partners Company Information
- 11.1.2 Altaris Capital Partners Novel Vaccine Delivery Systems Product Offered
- 11.1.3 Altaris Capital Partners Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)
- 11.1.4 Altaris Capital Partners Main Business Overview
- 11.1.5 Altaris Capital Partners Latest Developments
- 11.2 Kindeva Drug Delivery
- 11.2.1 Kindeva Drug Delivery Company Information
- 11.2.2 Kindeva Drug Delivery Novel Vaccine Delivery Systems Product Offered
- 11.2.3 Kindeva Drug Delivery Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)
- 11.2.4 Kindeva Drug Delivery Main Business Overview
- 11.2.5 Kindeva Drug Delivery Latest Developments
- 11.3 Becton
- 11.3.1 Becton Company Information
- 11.3.2 Becton Novel Vaccine Delivery Systems Product Offered
- 11.3.3 Becton Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)
- 11.3.4 Becton Main Business Overview
- 11.3.5 Becton Latest Developments
- 11.4 Dickinson,
- 11.4.1 Dickinson, Company Information
- 11.4.2 Dickinson, Novel Vaccine Delivery Systems Product Offered
- 11.4.3 Dickinson, Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)
- 11.4.4 Dickinson, Main Business Overview
- 11.4.5 Dickinson, Latest Developments
- 11.5 Carl Zeiss Foundation
- 11.5.1 Carl Zeiss Foundation Company Information
- 11.5.2 Carl Zeiss Foundation Novel Vaccine Delivery Systems Product Offered
- 11.5.3 Carl Zeiss Foundation Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)
- 11.5.4 Carl Zeiss Foundation Main Business Overview
- 11.5.5 Carl Zeiss Foundation Latest Developments
- 11.6 Gerresheimer AG
- 11.6.1 Gerresheimer AG Company Information
- 11.6.2 Gerresheimer AG Novel Vaccine Delivery Systems Product Offered
- 11.6.3 Gerresheimer AG Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)
- 11.6.4 Gerresheimer AG Main Business Overview
- 11.6.5 Gerresheimer AG Latest Developments
- 11.7 Corium International
- 11.7.1 Corium International Company Information
- 11.7.2 Corium International Novel Vaccine Delivery Systems Product Offered
- 11.7.3 Corium International Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)
- 11.7.4 Corium International Main Business Overview
- 11.7.5 Corium International Latest Developments
- 11.8 Inovio Pharmaceuticals
- 11.8.1 Inovio Pharmaceuticals Company Information
- 11.8.2 Inovio Pharmaceuticals Novel Vaccine Delivery Systems Product Offered
- 11.8.3 Inovio Pharmaceuticals Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)
- 11.8.4 Inovio Pharmaceuticals Main Business Overview
- 11.8.5 Inovio Pharmaceuticals Latest Developments
- 11.9 Bioject Medical Technologies
- 11.9.1 Bioject Medical Technologies Company Information
- 11.9.2 Bioject Medical Technologies Novel Vaccine Delivery Systems Product Offered
- 11.9.3 Bioject Medical Technologies Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)
- 11.9.4 Bioject Medical Technologies Main Business Overview
- 11.9.5 Bioject Medical Technologies Latest Developments
- 11.10 PharmaJet
- 11.10.1 PharmaJet Company Information
- 11.10.2 PharmaJet Novel Vaccine Delivery Systems Product Offered
- 11.10.3 PharmaJet Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)
- 11.10.4 PharmaJet Main Business Overview
- 11.10.5 PharmaJet Latest Developments
- 11.11 Retractable Technologies
- 11.11.1 Retractable Technologies Company Information
- 11.11.2 Retractable Technologies Novel Vaccine Delivery Systems Product Offered
- 11.11.3 Retractable Technologies Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)
- 11.11.4 Retractable Technologies Main Business Overview
- 11.11.5 Retractable Technologies Latest Developments
- 11.12 Terumo Corporation
- 11.12.1 Terumo Corporation Company Information
- 11.12.2 Terumo Corporation Novel Vaccine Delivery Systems Product Offered
- 11.12.3 Terumo Corporation Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)
- 11.12.4 Terumo Corporation Main Business Overview
- 11.12.5 Terumo Corporation Latest Developments
- 11.13 VAXXAS
- 11.13.1 VAXXAS Company Information
- 11.13.2 VAXXAS Novel Vaccine Delivery Systems Product Offered
- 11.13.3 VAXXAS Novel Vaccine Delivery Systems Revenue, Gross Margin and Market Share (2020-2022)
- 11.13.4 VAXXAS Main Business Overview
- 11.13.5 VAXXAS Latest Developments
12 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Novel Vaccine Delivery Systems. Industry analysis & Market Report on Novel Vaccine Delivery Systems is a syndicated market report, published as Global Novel Vaccine Delivery Systems Market Growth (Status and Outlook) 2022-2028. It is complete Research Study and Industry Analysis of Novel Vaccine Delivery Systems market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
